47 results
-
Bond Listing with a Foreign Approved Prospectus
Fast and Easy Access to the Swiss Debt Capital Market with a Foreign Approved Prospectus.
-
CONNEXOR
CONNEXOR allows for fully automated, cost-efficient management of reference data throughout a financial instrument's entire life cycle.
-
CONNEXOR Auto-ICPY Service
Fully automated IBE Income Payment instructions for Structured Products with fixed coupons
-
CONNEXOR Events
CONNEXOR Events is a service that allows issuers to automate their reporting processes for structured products, thereby making it easier to submit product event information electronically.
-
CONNEXOR® Distribution
Provisions
-
Enjoy the Benefits of Europe’s Leading Exchange for Life Sciences Companies
The Swiss Stock Exchange represents more than a third of the European Life Sciences market capitalization.
-
ETF Listing Process
List your ETFs easily and well guided on SIX Swiss Exchange
-
ETP Listing Process
List your ETPs easily and well guided on SIX Swiss Exchange
-
Evaluating the Aspects of a Swiss versus a US Listing
Why look further afield when you can have it in Switzerland?
-
FuW: 14 Kandidaten schnuppern am IPO, German
Die Schweizer Börse macht in der Sparks Academy hiesigen Start-ups aus verschiedenen Branchen einen Börsengang schmackhaft.
-
Go Public on SIX Swiss Exchange and Concurrently Access the US Capital Markets
By including a Rule 144A offering in your company’s IPO on SIX Swiss Exchange, you have the advantage of being able to access the US capital markets. This could help maximize the value of your company going public.
-
Going Public Media; Plattform Life Science Biotechnologie 2020, German
Die Schweizer Börse ist die führende europäische Börse für IPOs von Life Sciences Unternehmen
-
GoingPublic Magazine 2019: Special - Capital Market Switzerland
“Capital-rich investors create a good base for IPOs”
-
How SIX Swiss Exchange’s position as the leading European biotech exchange can help achieve global sustainability goals
-
Investor Relations Handbook: Compact Guide
As a share issuer and as a company primarily listed on the Swiss Stock Exchange, you have important information obligations towards your investors and the public. These duties serve to ensure continuous transparency about your company.
-
IPO Academy Program
-
IPO Academy Program
-
List Your Company Efficiently with Our Going Public Process
As an equity issuer, SIX offers you a complete package comprising everything you need for admission to the exchange. Our process for going public features short decision-making pathways, flexibility and reliability as well as close proximity to markets and customers. Expert contacts and helpful information support you throughout the whole process of going public.
-
Our Checklist Supports Your Being Public
As an equity issuer and primary listed company, you have a number of important duties to fulfil as regards informing your investors and the general public. These obligations for maintaining a listing serve to ensure transparency over your company at all times.
-
Plattform Life Sciences-Biotechnologie 2022; Sparks provides a welcome springboard for biotech SMEs on SIX Swiss Exchange
-
Primary Swiss Debt Capital Market Information FY 2023
-
Provisions CONNEXOR® Listing
-
Quick Style Guide
Sustainability is Increasingly in the Spotlight
-
Raising Capital Efficiently
The Bond Listing Guide of the SIX Swiss Exchange.
-
Schweizer Jahrbuch für Strukturierte Produkte 2019, German
-
Schweizer Jahrbuch für Strukturierte Produkte 2020, German
-
Securing Fair and Transparent Protection Offered by the Swiss Takeover Rules Through Being Listed on SIX
If a company lists its equity securities on a foreign exchange, this may have far-reaching implications with respect to takeover protection. The Swiss takeover rules only apply to companies respectively equity securities that have a primary listing on a Swiss exchange. Subsequently, a Swiss incorporated company being listed on a foreign exchange may be vulnerable to unsolicited takeovers.
-
SIX Sustainability Handbook
-
Sparks IPO Academy
-
Sparks: The SIX Swiss Exchange SME Exchange
-
Special Capital Market Switzerland 2020: The new Swiss prospectus regime
What an IPO candidate needs to know
-
Special «Kapitalmarkt Schweiz 2021»: Sparks Explained
Everything you need to know about the new SME segment.
-
Startup Magazine 2021: “Make Way for Sparks!”
Everything you need to know about the new SME stock exchange.
-
Swiss Biotech Association; Swiss Biotech Report 2019
Hero and bogeyman: The public face of leadership after an IPO
-
Swiss Biotech Association; Swiss Biotech Report 2020
Five-year stellar performance by Switzerland’s SXI Bio+Medtech Index
-
Swiss Biotech Report 2016
Record year for funding.
-
Swiss Biotech Report 2017
Reducing complexity as a function of strategy.
-
Swiss Biotech Report 2018
Retrospective: Biotech listings on SIX Swiss Exchange
-
Swiss Biotech Report 2020
Five-year stellar performance by SXI Bio+Medtech Index
-
Swiss Biotech Report 2021
SIX-listed biotechs light up exceptional trading year
-
Swiss Biotech report 2022
Sparks provides a welcome springboard for biotech SMEs on SIX Swiss Exchange
-
Swiss Biotech Report 2023
SIX Swiss Exchange: A safe haven in stormy times
-
Take Your Family Business to the Next Level. List on the Swiss Stock Exchange.
Lay the foundation for a seamless and transparent succession by going public with your family business.
-
The New Swiss Prospectus Regime
What You as an IPO Candidate Need to Know.
-
Usage Agreement CONNEXOR® Distribution
-
Usage Agreement CONNEXOR® Listing
-
Welcome to the Swiss Financial Center
Your Place for Raising Capital Efficiently.